1. Home
  2. AQMS vs HBIO Comparison

AQMS vs HBIO Comparison

Compare AQMS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

N/A

Current Price

$5.06

Market Cap

20.9M

Sector

Industrials

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$0.58

Market Cap

22.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
AQMS
HBIO
Founded
2014
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
22.1M
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
AQMS
HBIO
Price
$5.06
$0.58
Analyst Decision
Buy
Buy
Analyst Count
1
3
Target Price
$12.00
$2.50
AVG Volume (30 Days)
82.2K
415.6K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
$116,176,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
$7.80
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.28
52 Week High
$39.37
$0.95

Technical Indicators

Market Signals
Indicator
AQMS
HBIO
Relative Strength Index (RSI) 43.75 51.38
Support Level $4.62 $0.41
Resistance Level $8.37 $0.64
Average True Range (ATR) 0.34 0.04
MACD 0.05 0.01
Stochastic Oscillator 72.29 60.25

Price Performance

Historical Comparison
AQMS
HBIO

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: